Literature DB >> 16342252

Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.

Erkan Kurt1, Ping-Pin Zheng, Wim C J Hop, Marcel van der Weiden, Meike Bol, Martin J van den Bent, Cees J J Avezaat, Johan M Kros.   

Abstract

BACKGROUND: The results of attempts to identify histopathologic parameters that contribute to the clinical outcome of patients with ependymomas have been controversial. This may be due to the relative rareness of ependymomas. Furthermore, in many investigations, myxopapillary ependymomas and subependymomas were included and may have confounded results, because those tumors should be considered clinicopathologic entities distinct from the other ependymomas.
METHODS: In this retrospective study, the influence of the histologic subtype of ependymoma and of individual histologic features on the outcome of 69 patients with ependymomas was investigated. Myxopapillary ependymomas, subependymomas, and ependymomas with spinal localizations were excluded from the analysis. The ependymomas were subdivided into cellular, papillary, clear cell, and tanycytic subtypes. The study extended over a period of 30 years.
RESULTS: No differences in clinical outcome between the four histologic subtypes of ependymomas were revealed. Neither tumor localization (either infratentorial or supratentorial), patient age, nor gender affected survival. The survival of patients who underwent complete tumor resection differed significantly from that of patients who underwent partial resection. In univariate analysis, the features of nuclear atypia, the mitotic index, and the MIB-1 labeling index (LI) significantly influenced survival. With regard to survival, the presence of microcysts, blood vessel density, and the feature of vascular hyalinization demonstrated a trend but did not reach significance. In multivariate analysis, only the mitotic index and the MIB-1 LI were identified as factors with independent prognostic significance (P = 0.027 and P = 0.023, respectively). Both proliferation indices were correlated strongly with each other.
CONCLUSIONS: The results of the univariate analysis indicated that, for patients with intracranial ependymoma, nuclear atypia, the mitotic index, and the MIB-1 LI significantly influenced survival. In the multivariate analysis, the mitotic index and the MIB-1 LI were the only features that had independent prognostic significance. Because both showed strong correlations, only one of them should be included in a grading scheme for intracranial ependymomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16342252     DOI: 10.1002/cncr.21608

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

Review 1.  Immunohistochemical prognostic markers in intracranial ependymomas: systematic review and meta-analysis.

Authors:  Klara Kuncova; Ales Janda; Pavel Kasal; Josef Zamecnik
Journal:  Pathol Oncol Res       Date:  2009-03-20       Impact factor: 3.201

2.  Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas.

Authors:  Rakesh Kumar Gupta; Mehar C Sharma; Vaishali Suri; Aanchal Kakkar; Manmohan Singh; Chitra Sarkar
Journal:  J Neurooncol       Date:  2013-11-01       Impact factor: 4.130

3.  Prognostic marker analysis in pediatric intracranial ependymomas.

Authors:  Roger E McLendon; Eric Lipp; Diane Satterfield; Melissa Ehinger; Alan Austin; Debra Fleming; Kathryn Perkinson; Michaela Lefaivre; David Zagzag; Benjamin Wiener; Sri Gururangan; Herbert Fuchs; Henry S Friedman; James E Herndon; Patrick Healy
Journal:  J Neurooncol       Date:  2015-01-07       Impact factor: 4.130

4.  Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients.

Authors:  Philippe Metellus; Jacques Guyotat; Olivier Chinot; Anne Durand; Marylin Barrie; Roch Giorgi; Anne Jouvet; Dominique Figarella-Branger
Journal:  Neuro Oncol       Date:  2010-05-19       Impact factor: 12.300

5.  Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.

Authors:  Rebecca Senetta; Clelia Miracco; Salvatore Lanzafame; Luigi Chiusa; Rosario Caltabiano; Antonio Galia; Giulia Stella; Paola Cassoni
Journal:  Neuro Oncol       Date:  2010-11-08       Impact factor: 12.300

6.  Evaluation of chromosome 1q gain in intracranial ependymomas.

Authors:  Madhu Rajeshwari; Mehar Chand Sharma; Aanchal Kakkar; Aruna Nambirajan; Vaishali Suri; Chitra Sarkar; Manmohan Singh; Ravindra Kumar Saran; Rakesh Kumar Gupta
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

7.  Anaplastic myxopapillary ependymoma in an infant: Case report and literature review.

Authors:  Darshan Trivedi; Zhenggang Xiong
Journal:  Intractable Rare Dis Res       Date:  2017-05

Review 8.  Classification and controversies in pathology of ependymomas.

Authors:  Catherine Godfraind
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

Review 9.  Survival following treatment for intracranial ependymoma: a review.

Authors:  G Tamburrini; M D'Ercole; B L Pettorini; M Caldarelli; L Massimi; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-04-22       Impact factor: 1.475

10.  Recurrent pituitary ependymoma: a complex clinical problem.

Authors:  Rosie Belcher; Harvinder S Chahal; Jane Evanson; Farhad Afshar; Silvia Marino; Ashley B Grossman
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.